Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry

H U Irgens1, J Molnes, B B Johansson

  • 1KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway.

Diabetologia
|April 30, 2013
PubMed

Insights

Monogenic diabetes (MD) is often misdiagnosed as type 1 diabetes in children. This study found MD in 1.1% of children in the Norwegian Childhood Diabetes Registry, highlighting the need for accurate diagnosis.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Monogenic diabetes (MD) can be misdiagnosed as type 1 diabetes in pediatric patients.
  • The prevalence of MD in children with apparent type 1 diabetes is not well-established.
  • Accurate diagnosis is crucial for appropriate treatment and management of childhood diabetes.

Purpose of the Study:

  • To estimate the prevalence of common forms of monogenic diabetes (MD) in children.
  • To investigate the diagnostic accuracy of current methods for identifying MD in pediatric diabetes cases.
  • To establish the frequency of MD within a nationwide childhood diabetes registry.

Main Methods:

  • A nationwide population-based study of 2,756 children (aged 0-14 years) with newly diagnosed diabetes was conducted.
  • Genetic screening for mutations in key genes (KCNJ11, ABCC8, INS, HNF1A, HNF4A, MT-TL1, GCK) was performed based on clinical criteria.
  • Data from the Norwegian Childhood Diabetes Registry and the Norwegian MODY Registry were utilized.

Main Results:

  • Mutations were identified in 1.1% of children within the Norwegian Childhood Diabetes Registry.
  • Specifically, mutations in HNF1A (15 children), GCK (9 children), KCNJ11 (4 children), and INS (1 child) were found.
  • An additional 24 children with glucokinase-MODY were identified through the Norwegian MODY Registry, indicating a minimum prevalence of 3.1/100,000 for MD in Norwegian children.

Conclusions:

  • This study provides the first prevalence data for common forms of MD in a nationwide childhood diabetes registry.
  • Monogenic diabetes accounts for a significant proportion of childhood diabetes cases previously misdiagnosed.
  • Improved genetic screening and diagnostic approaches are essential for identifying MD in children.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...